Life Sciences
Jayme Strauss, Precision Neuroscience's chief clinical and commercial officer, kicks off the Emerging Technologies series, discussing how the company's brain-computer interface, Layer 7, works and what it hopes to accomplish for patients.
The funds will be dispersed over the next five years to develop innovations aimed at enhancing the healthcare journey for patients.
The collaboration addresses delays in diagnosis and treatment by leveraging AI to help ensure patients with prostate and breast cancer are identified and treated more promptly.
Talkspace members will be able to fill prescriptions from their Talkspace provider through Amazon Pharmacy.
The Southern New Jersey health system discovered that certain data stored in its systems was potentially acquired without authorization.
The next-generation Swoop system software enhances image quality for ultra-low-field magnetic resonance imaging.
The company will use the funds to expand operations in the EU and U.S.
The orchestrator includes customizable, multimodal AI agents to streamline oncology workflows like tumor boards and improve clinical decision-making.
The funds will be used to support building a GMP system for long-acting injectables and grow the company's robotic lab.
HIMSS25
Genetic therapy is effective but can cost millions of dollars. Boro Dropulić, executive director of Caring Cross, says technology innovations and partnerships with hospitals and governments can help lower costs and increase accessibility.